Notice Number: NOT-EB-20-003

Key Dates
Release Date: March 18, 2020

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate, effective immediately, in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)".

The following changes and updates are made to PA-20-135 (shown in italics) to reflect NIBIB participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Human Genome Research Institute (NHGRI)

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.213, 93.393, 93.394, 93.395, 93.396, 93.399, 93.172, 93.855, 93.865, 93.847, 93.113, 93.142, 93.143, 93.859, 93.307, 93.286

All other aspects of this Notice remain the same.

Inquiries

Please direct all inquiries to:

Todd Merchak
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8592
Email: merchakt@mail.nih.gov